Table of Contents Author Guidelines Submit a Manuscript
International Journal of Nephrology
Volume 2017, Article ID 5819629, 7 pages
https://doi.org/10.1155/2017/5819629
Review Article

Dialysis Provision and Implications of Health Economics on Peritoneal Dialysis Utilization: A Review from a Malaysian Perspective

1Department of Community Health, Faculty of Medicine, Pusat Perubatan Universiti Kebangsaan Malaysia, Jalan Yaacob Latif, Bandar Tun Razak, 56000 Cheras, Kuala Lumpur, Malaysia
2Nephrology Unit, Faculty of Medicine, Pusat Perubatan Universiti Kebangsaan Malaysia, Jalan Yaacob Latif, Bandar Tun Razak, 56000 Cheras, Kuala Lumpur, Malaysia
3Hospital Sultanah Aminah, Jalan Persiaran Abu Bakar Sultan, 80100 Johor Bahru, Johor, Malaysia
4Hospital Kuala Lumpur, Jalan Pahang, 50586 Kuala Lumpur, Malaysia

Correspondence should be addressed to Naren Kumar Surendra; moc.liamg@esiurc.neran

Received 31 July 2017; Accepted 4 October 2017; Published 31 October 2017

Academic Editor: Franca Anglani

Copyright © 2017 Mohd Rizal Abdul Manaf et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Economic Planning Unit, “The Malaysian Economy in Figures,” Prime Minister's Department, 2017. View at Google Scholar
  2. Department of Statistics Malaysia, “Population and Demography: Abridged Life Tables, Malaysia,” 2013–2016, https://www.dosm.gov.my/v1/index.php?r=column/cthemeByCat&cat=116&bul_id=TkpmM05EK3NBV0JRU1pmOUJnS3RCQT09&menu_id=L0pheU43NWJwRWVSZklWdzQ4TlhUUT09. View at Google Scholar
  3. World Health Organization, “Malaysian Health System review,” 2013. View at Google Scholar
  4. Ministry of Health Malaysia, “Health Expenditure Report 1997-2013,” Planning Division, 2015. View at Google Scholar
  5. O. E. Ayodele and C. O. Alebiosu, “Burden of chronic kidney disease: an international perspective,” Advances in Chronic Kidney Disease, vol. 17, no. 3, pp. 215–224, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. Fresinius Medical Care, “Magazine 2013 Perspectives,” http://www.equitystory.com/download/companies/fmc/Annual%20Reports/DE0005785802-JA-2013-EQ-E-00.pdf.
  7. World Health Organization, “Global Burden of Disease.: Regional Estimates for 2000–2015, DALY Estimates,” http://www.who.int/healthinfo/global_burden_disease/estimates/en/index2.html.
  8. Institute of Health Metrics and Evaluation, “Global Burden of Disease Study 2015,” http://ghdx.healthdata.org/gbd-results-tool.
  9. S. Bele, T. N. Bodhare, N. Mudgalkar, A. Saraf, and S. Valsangkar, “Health-related quality of life and existential concerns among patients with end-stage renal disease,” Indian Journal of Palliative Care, vol. 18, no. 2, pp. 103–108, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. W. G. Couser, G. Remuzzi, S. Mendis, and M. Tonelli, “The contribution of chronic kidney disease to the global burden of major noncommunicable diseases,” Kidney International, vol. 80, no. 12, pp. 1258–1270, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. B. G. Jaar, A. Chang, and L. Plantinga, “Can we improve quality of life of patients on dialysis?” Clinical Journal of the American Society of Nephrology, vol. 8, no. 1, pp. 1–4, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. The National Renal Registry, 22nd Report of the Malaysian Dialysis and Transplant Registry, 2015.
  13. A. Ojo, “Addressing the global burden of chronic kidney disease through clinical and translational research,” Transactions of the American Clinical and Climatological Association, vol. 125, pp. 6–229, 2014. View at Google Scholar · View at Scopus
  14. A. S. Levey, R. Atkins, J. Coresh et al., “Chronic kidney disease as a global public health problem: approaches and initiatives—a position statement from Kidney Disease Improving Global Outcomes,” Kidney International, vol. 72, no. 3, pp. 247–259, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. F. X. Liu, T. P. Quock, and J. Burkart, “Economic evaluations of peritoneal dialysis and hemodialysis: 2004–2012,” F1000Research, vol. 2, no. 273, pp. 1–13, 2013. View at Publisher · View at Google Scholar
  16. A. N. Karopadi, G. Mason, E. Rettore, and C. Ronco, “Cost of peritoneal dialysis and haemodialysis across the world,” Nephrology Dialysis Transplantation , vol. 28, no. 10, pp. 2553–2569, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. E. Grapsa, “Is the underutilization of peritoneal dialysis in relation to hemodialysis, as renal replacement therapy, justifiable worldwide? yes or no,” Hippokratia, vol. 15, no. 1, pp. 13–15, 2011. View at Google Scholar · View at Scopus
  18. T.-O. Lim, A. Goh, Y.-N. Lim, Z. M. M. Zaher, and A. B. Suleiman, “How public and private reforms dramatically improved access to dialysis therapy in Malaysia,” Health Affairs, vol. 29, no. 12, pp. 2214–2222, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. H. T. Chua and J. C. H. Cheah, “Financing universal coverage in Malaysia: A case study,” BMC Public Health, vol. 12, no. 1, article no. S7, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. J. B. Wetmore and A. J. Collins, “Global challenges posed by the growth of end-stage renal disease,” Renal Replacement Therapy, vol. 2, no. 1, pp. 1–7, 2016. View at Publisher · View at Google Scholar
  21. S. L. White, S. J. Chadban, S. Jan, J. R. Chapman, and A. Cass, “How can we achieve global equity in provision of renal replacement therapy?” Bulletin of the World Health Organization, vol. 86, no. 3, pp. 229–237, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. C. Tan, C. Chan, C. Ho, K. S. Wong, E. J. Lee, and K. T. Woo, “Health economics of renal replacement therapy: Perspectives from Singapore,” Kidney International, vol. 67, no. 94, pp. S19–S22, 2015. View at Publisher · View at Google Scholar
  23. Medical Development Division, “Ministry of Health Malaysia, Nephrology services operational policy, 2010”.
  24. M. A. Bujang, T. H. Adnan, N. H. Hashim et al., “Forecasting the Incidence and Prevalence of Patients with End-Stage Renal Disease in Malaysia up to the Year 2040,” International Journal of Nephrology, vol. 2017, Article ID 2735296, 2017. View at Publisher · View at Google Scholar · View at Scopus
  25. L. S. Hooi, T. O. Lim, A. Goh et al., “Economic evaluation of centre haemodialysis and continuous ambulatory peritoneal dialysis in Ministry of Health hospitals, Malaysia,” Nephrology, vol. 10, no. 1, pp. 25–32, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. N. Lameire and W. van Biesen, “Epidemiology of peritoneal dialysis: a story of believers and nonbelievers,” Nature Reviews Nephrology, vol. 6, no. 2, pp. 75–83, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. P. Dalal, H. Sangha, and K. Chaudhary, “In peritoneal dialysis, is there sufficient evidence to make ‘PD first’ therapy?” International Journal of Nephrology, vol. 2011, Article ID 239515, 5 pages, 2011. View at Publisher · View at Google Scholar
  28. M. Novak, F. Bender, and B. Piraino, “Why is peritoneal dialysis underutilized in the United States?” Dialysis & Transplantation, vol. 37, no. 3, p. 1, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. R. J. Fluck, D. Fouque, and R. S. Lockridge Jr., “Nephrologists' perspectives on dialysis treatment: Results of an international survey,” BMC Nephrology, vol. 15, no. 1, article no. 16, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Anand, A. Bitton, and T. Gaziano, “The Gap between Estimated Incidence of End-Stage Renal Disease and Use of Therapy,” PLoS ONE, vol. 8, no. 8, Article ID e72860, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. T. Liyanage, T. Ninomiya, V. Jha et al., “Worldwide access to treatment for end-stage kidney disease: a systematic review,” The Lancet, vol. 385, no. 9981, pp. 1975–1982, 2015. View at Publisher · View at Google Scholar · View at Scopus
  32. Institute for Public Health, “National Health and Morbidity Survey 2015 Vol. II: Non-Communicable Diseases, Risk Factors and Other Health Problems,” Ministry of Health Malaysia, 2015.
  33. L. S. Hooi, L. M. Ong, G. Ahmad et al., “A population-based study measuring the prevalence of chronic kidney disease among adults in West Malaysia,” Kidney International, vol. 84, no. 5, pp. 1034–1040, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. P. M. Just, F. T. De Charro, E. A. Tschosik, L. L. Noe, S. K. Bhattacharyya, and M. C. Riella, “Reimbursement and economic factors influencing dialysis modality choice around the world,” Nephrology Dialysis Transplantation , vol. 23, no. 7, pp. 2365–2373, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. National Kidney Foundation, “A-Z Health Guide,” https://www.kidney.org/atoz.
  36. M. J. Oliver, R. R. Quinn, E. P. Richardson, A. J. Kiss, D. L. Lamping, and B. J. Manns, “Home care assistance and the utilization of peritoneal dialysis,” Kidney International, vol. 71, no. 7, pp. 673–678, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. N. Lameire, P. Peeters, R. Vanholder, and W. Van Biesen, “Peritoneal dialysis in Europe: An analysis of its rise and fall,” Blood Purification, vol. 24, no. 1, pp. 107–114, 2006. View at Publisher · View at Google Scholar · View at Scopus
  38. J.-P. Wauters and D. Uehlinger, “Non-medical factors influencing peritoneal dialysis utilization: The Swiss experience,” Nephrology Dialysis Transplantation , vol. 19, no. 6, pp. 1363–1367, 2004. View at Publisher · View at Google Scholar · View at Scopus
  39. M. F. Drummond, M. J. Sculpher, G. W. Torrance, B. J. OBrien, and G. L. Stoddart, Methods for the Economic Evaluation of Health Care Programmes, Oxford University Press, 3rd edition, 2005.
  40. J. B. Oostenbrink, M. A. Koopmanschap, and F. F. H. Rutten, “Standardisation of costs: The Dutch Manual for Costing in Economic Evaluations,” PharmacoEconomics, vol. 20, no. 7, pp. 443–454, 2002. View at Publisher · View at Google Scholar · View at Scopus
  41. P. Dhanakijcharoen, D. Sirivongs, S. Aruyapitipan, P. Chuengsaman, and A. Lumpaopong, “The ‘PD First’ policy in Thailand: three-years experiences (2008–2011),” Journal of the Medical Association of Thailand, vol. 94, supplement 4, pp. S153–S161, 2011. View at Google Scholar · View at Scopus
  42. Y. Teerawattananon, M. Mugford, and V. Tangcharoensathien, “Economic evaluation of palliative management versus peritoneal dialysis and hemodialysis for end-stage renal disease: Evidence for coverage decisions in Thailand,” Value in Health, vol. 10, no. 1, pp. 61–72, 2007. View at Publisher · View at Google Scholar · View at Scopus
  43. A. S.-M. Choy and P. K.-T. Li, “Sustainability of the Peritoneal Dialysis-First Policy in Hong Kong,” Blood Purification, vol. 40, no. 4, pp. 320–325, 2015. View at Publisher · View at Google Scholar · View at Scopus
  44. F. X. Liu, X. Gao, G. Inglese, P. Chuengsaman, R. Pecoits-Filho, and A. Yu, “A global overview of the impact of peritoneal dialysis first or favored policies: an opinion,” Peritoneal Dialysis International, 2014. View at Publisher · View at Google Scholar
  45. United States Renal Data System (USRD), “Chapter 13: Mortality,” https://www.usrds.org/2015/view/v2_13.aspx.
  46. D. C. Mendelssohn, N. Langlois, and P. G. Blake, “Peritoneal dialysis in Ontario: A natural experiment in physician reimbursement methodology,” Peritoneal Dialysis International, vol. 24, no. 6, pp. 531–537, 2004. View at Google Scholar · View at Scopus
  47. H. Naito, “The Japanese health-care system and reimbursement for dialysis,” Peritoneal Dialysis International, vol. 26, no. 2, pp. 155–161, 2006. View at Google Scholar · View at Scopus
  48. Y.-C. Lin, Y.-C. Lin, C.-C. Kao, H.-H. Chen, C.-C. Hsu, and M.-S. Wu, “Health policies on dialysis modality selection: A nationwide population cohort study,” BMJ Open, vol. 7, no. 1, Article ID e013007, 2017. View at Publisher · View at Google Scholar · View at Scopus
  49. T. A. Golper, “The possible impact of the us prospective payment system ("bundle") on the growth of peritoneal dialysis,” Peritoneal Dialysis International, vol. 33, no. 6, pp. 596–599, 2013. View at Publisher · View at Google Scholar · View at Scopus
  50. Q. Zhang, M. Thamer, O. Kshirsagar, and Y. Zhang, “Impact of the End Stage Renal Disease Prospective Payment System on the Use of Peritoneal Dialysis,” Kidney International Reports, vol. 2, no. 3, pp. 350–358, 2017. View at Publisher · View at Google Scholar
  51. Z. Morad, D. G. Lee, Y. N. Lim, and P. C. Tan, “Peritoneal dialysis in Malaysia,” Peritoneal Dialysis International, vol. 25, no. 5, pp. 426–431, 2005. View at Google Scholar · View at Scopus
  52. S. Bavanandan, G. Ahmad, A.-H. Teo, L. Chen, and F. X. Liu, “Budget Impact Analysis of Peritoneal Dialysis versus Conventional In-Center Hemodialysis in Malaysia,” Value in Health Regional Issues, vol. 9, pp. 8–14, 2016. View at Publisher · View at Google Scholar · View at Scopus
  53. X. Sun, “Markov modelling in healthcare economic evaluations,” Chinese Journal of Evidence-Based Medicine, vol. 7, no. 10, pp. 750–756, 2007. View at Google Scholar · View at Scopus
  54. C. Treharne, F. X. Liu, M. Arici, L. Crowe, and U. Farooqui, “Peritoneal dialysis and in-centre haemodialysis: A cost-utility analysis from a UK payer perspective,” Applied Health Economics and Health Policy, vol. 12, no. 4, pp. 409–420, 2014. View at Publisher · View at Google Scholar · View at Scopus
  55. M. Haller, G. Gutjahr, R. Kramar, F. Harnoncourt, and R. Oberbauer, “Cost-effectiveness analysis of renal replacement therapy in Austria,” Nephrology Dialysis Transplantation , vol. 26, no. 9, pp. 2988–2995, 2011. View at Publisher · View at Google Scholar · View at Scopus
  56. K. Howard, G. Salkeld, S. White et al., “The cost-effectiveness of increasing kidney transplantation and home-based dialysis,” Nephrology, vol. 14, no. 1, pp. 123–132, 2009. View at Publisher · View at Google Scholar · View at Scopus
  57. Y. Almualm and H. Zaman Huri, “Chronic kidney disease screening methods and its implication for Malaysia: an in depth review,” Global Journal of Health Science, vol. 7, no. 4, pp. 96–109, 2015. View at Publisher · View at Google Scholar · View at Scopus
  58. L. S. Hooi, H. S. Wong, and Z. Morad, “Prevention of renal failure: the Malaysian experience,” Kidney International Supplements, vol. 67, no. 94, pp. S70–S74, 2005. View at Publisher · View at Google Scholar · View at Scopus
  59. Medical Development Division, “Ministry of Health Malaysia, Management of Chronic Kidney Disease in Adults,” 2011.
  60. International Registry for organ donation and transplantation, “Final numbers 2014. 2015,” http://www.irodat.org/img/database/pdf/NEWSLETTER2015_December2.pdf.
  61. Medical Development Division, “Ministry of Health Malaysia, Palliative Care Services Operational Policy,” 2010.
  62. L. P. Wong, K. T. Yamamoto, V. Reddy et al., “Patient education and care for peritoneal dialysis catheter placement: A quality improvement study,” Peritoneal Dialysis International, vol. 34, no. 1, pp. 12–23, 2014. View at Publisher · View at Google Scholar · View at Scopus
  63. P. G. Blake, R. R. Quinn, and M. J. Oliver, “Peritoneal dialysis and the process of modality selection,” Peritoneal Dialysis International, vol. 33, no. 3, pp. 233–241, 2013. View at Publisher · View at Google Scholar · View at Scopus
  64. K. Chaudhary, H. Sangha, and R. Khanna, “Peritoneal dialysis first: rationale,” Clinical Journal of the American Society of Nephrology, vol. 6, no. 2, pp. 447–456, 2011. View at Publisher · View at Google Scholar · View at Scopus
  65. A. Figueiredo, B.-L. Goh, S. Jenkins et al., “Clinical practice guidelines for peritoneal access,” Peritoneal Dialysis International, vol. 30, no. 4, pp. 424–429, 2010. View at Publisher · View at Google Scholar · View at Scopus